Renal anaemia treatment with recombinant human erythropoietin increases cardiac output in patients with ischaemic heart disease

Scandinavian Journal of Urology and Nephrology

Volumn 30, Issue 2, 1996, Pages 115-120

  Linde, Torbjörn ^a   Wikström, Björn ^a   Andersson, Lars Göran ^a   Danielson, Bo G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic renal failure; Erythropoietin; Haemodynamics; Haemtocrit; Hypertension; Ischaemic heart disease

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; THALLIUM 201;

ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART OUTPUT; HEMATOCRIT; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029933753     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365599609180900     Document Type: Article

References (27)

1. Abdulhadi MH, Fouad-Tarazi FM, Thomas T, Bravo EL, Paganini EP. The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin. Nephrol Dial Transplant 1990; (Suppl 1): 102-108.
2. Buckner FS, Eschbach JW, Haley NR, Davidson RC, Adamson JW. Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertens 1990; 3: 947-955.
3. Cannella G, LaCanna G, Sandrini M, Gaggiotti M, Nordio G, Movilli E, Maiorca R. Renormalization of high cardiac output and left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients. Clin Nephrol 1990; 34: 272-278.
4. Crystal GJ, Salem MR. Myocardial oxygen consumption and segmental shortening during selective coronary hemodilution in dogs. Anesth Analg 1988; 67: 500-508.
5. Gisselsson L, Rosberg B, Ericsson M. Myocardial blood flow, oxygen uptake and carbon-dioxide release of the human heart during hemodilution. Acta Anesth Scand 1982; 26: 589-591.
6. Gould KL. Agreement on the accuracy of thallium stress testing [editorial; comment]. J Am Coll Cardiol 1990; 16: 1022-1023.
7. Hori K, Onoyama K, Iseki K, Fujimi S, Fujishima M. Hemodynamic and volume changes by recombinant human erythropoietin (rhEPO) in the treatment of anemic hemodialysis patients. Clin Nephrol 1990; 33: 293-298.
8. Ikram H, Lynn KL, Bailey RR, Little PJ. Cardiovascular changes in chronic hemodialysis patients. Kidney Int 1983; 24: 371-376.
9. Iskandrian AS. SPECT thallium imaging in the diagnosis of myocardial ischemia [editorial; comment]. J Am Coll Cardiol 1990; 16: 1024-1025.
10. Kamata K, Marumo F, Onoyama K. Hemodynamic mechanism of the elevation in blood pressure following the improvement of anemia with recombinant human erythropoietin. Japanese Circulation Journal 1991; 55: 649-656.
11. London GM, Zins B, Pannier B, Naret C, Berthelot J, Jacquot C, Safar M, Drueke TB. Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int 1989; 36: 878-882.
12. Mannting F. A new method for quantification of pulmonary thallium uptake in myocardial SPECT studies. Eur J Nucl Med 1990; 16: 213-222.
13. Martinez VA, Bardaji A, Garcia C, Ridao C, Richart C, Oliver JA. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis. Am J Kidney Dis 1992; 19: 353-357.
14. Mayer G, Cada EM, Watzinger U, Barnas U, Graf H. Hemodynamic effects of partial correction of chronic anemia by recombinant human erythropoietin in patients on dialysis. Am J Kidney Dis 1991; 17: 286-289.
15. Mehlsen J, Bonde J, Stadeager C, Rehling M, Tangö M, Tarp-Jensen J. Reliability of impedance cardiography in measuring central haemodynamics. Clinical Physiology 1991; 11: 579-588.
16. Neff MS, Kim KE, Persoff M, Onesti G, Swartz C. Hemodynamics of uremic anemia. Circulation 1971; 43: 876-883.
17. Nonnast-Daniel B, Deschodt G, Brunkhorst R, Creutzig A, Bahlmann J, Shaldon S, Koch KM. Long-term effects of treatment with recombinant human erythropoietin on haemodynamics and tissue oxygenation in patients with renal anaemia. Nephrol Dial Transplant 1990; 5: 444-448.
18. Pascual J, Teruel JL, Marcen R, Liano F, Moya JL, Jimenez M, Ortuno J. Hemodynamic and cardiac effects of erythropoietin in patients on regular dialysis. Int J Artif Organs 1992; 15: 349-353.
19. Pickett BR, Buell JC. Validity of cardiac output measurement by computer-averaged impedance cardiography, and comparison with simultaneous thermodilution determinations. Am J Cardiol 1992; 69: 1354-1358.
20. Satoh K, Masuda T, Ikeda Y, Kurokawa S, Kamata K, Kikawada R, Takamoto T, Marumo F. Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients. Hypertension 1990; 15: 262-266.
21. Schwartz AB, Prior JE, Mintz GS, Kim KE, Kahn SB. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant human erythropoietin. Transplant Proc 1991; 23: 1827-1830.
22. Sramek B. Hemodynamic and pump-performance monitoring by electrical bioimpedance. Problems in Respiratory Care 1989; 2: 274-290.
23. Teruel JL, Pascual J, Jimenez M, Liano F, Rivera M, Martinez J, Moya JL, Ortuno J. Hemodynamic changes in hemodialyzed patients during treatment with recombinant human erythropoietin. Nephron 1991; 58: 135-137.
24. Thomas SU. Impedance cardiography using the Sramek-Bernstein method: accuracy and variability at rest and during exercise. Br J Clin Pharmacol 1992; 34: 467-476.
25. Vara-Thorbeck R, Guerrero-Fernandez Marcote JA. Hemodynamic response of elderly patients undergoing major surgery under moderate normovolemic hemodilution. Eur Surg Res 1985; 17: 372-376.
26. Verbeelen D, Bossuyt A, Smitz J, Herman A, Dratwa M, Jonckheer MH. Hemodynamics of patients with renal failure treated with recombinant human erythropoietin. Clin Nephrol 1989; 31; 6-11.
27. Vincenti F, Amend WJ, Abele J, Feduska NJ, Salvatierro O. The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 1980; 68: 363-369.